Helsingborg Hospital begins biobank sample collection for the REDUSE trial
- Dec 20, 2024
- 1 min read
(December 20) Helsingborg Hospital has become the first hospital to collect biobank samples as part of the REDUSE trial.
Sites involved in the biobank part of the REDUSE trial will collect blood samples at three intervals: at inclusion, and on days 3 and 5 following randomization. These samples, processed and stored in regional biobanks, will facilitate future analysis of biomarkers. An analysis plan will be discussed with all collaborators.
Helsingborg Hospital sets the stage for other sites to follow, helping to improve understanding and care for patients with septic shock.
While searching online, I found a women’s health gynaecology therapy service in London London, and the staff made me feel comfortable and well-informed. https://thelunaclinic.com/
A remarkable milestone for Helsingborg Hospital and the REDUSE trial! Initiating biobank sample collection is a critical step toward advancing our understanding of septic shock and developing targeted treatments through biomarker analysis.
At Chughtai Labs Pakistan, we recognise the vital role biobanking and diagnostic innovation play in research-driven healthcare. With our own focus on advanced diagnostics and Home Sample Collection Services, we're committed to supporting data-driven care that improves outcomes for patients.
Wishing continued success to the REDUSE collaborators on this important clinical journey. Learn more about our services here: https://chughtailab.com/home-sampling/